Stool microbiota and vaccine responses of infants
- PMID: 25002669
- PMCID: PMC4187229
- DOI: 10.1542/peds.2013-3937
Stool microbiota and vaccine responses of infants
Abstract
Objective: Oral vaccine efficacy is low in less-developed countries, perhaps due to intestinal dysbiosis. This study determined if stool microbiota composition predicted infant oral and parenteral vaccine responses.
Methods: The stool microbiota of 48 Bangladeshi infants was characterized at 6, 11, and 15 weeks of age by amplification and sequencing of the 16S ribosomal RNA gene V4 region and by Bifidobacterium-specific, quantitative polymerase chain reaction. Responses to oral polio virus (OPV), bacille Calmette-Guérin (BCG), tetanus toxoid (TT), and hepatitis B virus vaccines were measured at 15 weeks by using vaccine-specific T-cell proliferation for all vaccines, the delayed-type hypersensitivity skin-test response for BCG, and immunoglobulin G responses using the antibody in lymphocyte supernatant method for OPV, TT, and hepatitis B virus. Thymic index (TI) was measured by ultrasound.
Results: Actinobacteria (predominantly Bifidobacterium longum subspecies infantis) dominated the stool microbiota, with Proteobacteria and Bacteroidetes increasing by 15 weeks. Actinobacteria abundance was positively associated with T-cell responses to BCG, OPV, and TT; with the delayed-type hypersensitivity response; with immunoglobulin G responses; and with TI. B longum subspecies infantis correlated positively with TI and several vaccine responses. Bacterial diversity and abundance of Enterobacteriales, Pseudomonadales, and Clostridiales were associated with neutrophilia and lower vaccine responses.
Conclusions: Bifidobacterium predominance may enhance thymic development and responses to both oral and parenteral vaccines early in infancy, whereas deviation from this pattern, resulting in greater bacterial diversity, may cause systemic inflammation (neutrophilia) and lower vaccine responses. Vaccine responsiveness may be improved by promoting intestinal bifidobacteria and minimizing dysbiosis early in infancy.
Keywords: Actinobacteria; Bangladesh; Bifidobacterium; Proteobacteria; T lymphocyte; antibody; hepatitis; intestinal; microbiota; polio; tetanus; tuberculosis; vaccine.
Copyright © 2014 by the American Academy of Pediatrics.
Figures







Similar articles
-
Bifidobacterium Abundance in Early Infancy and Vaccine Response at 2 Years of Age.Pediatrics. 2019 Feb;143(2):e20181489. doi: 10.1542/peds.2018-1489. Pediatrics. 2019. PMID: 30674610 Free PMC article. Clinical Trial.
-
Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination.J Immunol. 2002 Jan 15;168(2):919-25. doi: 10.4049/jimmunol.168.2.919. J Immunol. 2002. PMID: 11777990 Clinical Trial.
-
Infant cortisol stress-response is associated with thymic function and vaccine response.Stress. 2019 Jan;22(1):36-43. doi: 10.1080/10253890.2018.1484445. Epub 2018 Jun 22. Stress. 2019. PMID: 29932814 Free PMC article. Clinical Trial.
-
Antibody responses of healthy infants to concurrent administration of a bivalent haemophilus influenzae type b-hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines.BioDrugs. 2001;15(6):413-8. doi: 10.2165/00063030-200115060-00007. BioDrugs. 2001. PMID: 11520252 Review.
-
The influence of the intestinal microbiome on vaccine responses.Vaccine. 2018 Jul 16;36(30):4433-4439. doi: 10.1016/j.vaccine.2018.04.066. Epub 2018 Jun 13. Vaccine. 2018. PMID: 29909134 Review.
Cited by
-
Dietary supplementation with Bifidobacterium longum subsp. infantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial.Trials. 2016 Jul 22;17(1):340. doi: 10.1186/s13063-016-1467-1. Trials. 2016. PMID: 27449926 Free PMC article. Clinical Trial.
-
Comparisons of the effect of naturally acquired maternal pertussis antibodies and antenatal vaccination induced maternal tetanus antibodies on infant's antibody secreting lymphocyte responses and circulating plasma antibody levels.Hum Vaccin Immunother. 2016 Apr 2;12(4):886-93. doi: 10.1080/21645515.2015.1136759. Hum Vaccin Immunother. 2016. PMID: 27176823 Free PMC article.
-
Discovery of Predictors of Mycoplasma hyopneumoniae Vaccine Response Efficiency in Pigs: 16S rRNA Gene Fecal Microbiota Analysis.Microorganisms. 2020 Jul 29;8(8):1151. doi: 10.3390/microorganisms8081151. Microorganisms. 2020. PMID: 32751315 Free PMC article.
-
Microbiomics: The Next Pillar of Precision Medicine and Its Role in African Healthcare.Front Genet. 2022 Apr 5;13:869610. doi: 10.3389/fgene.2022.869610. eCollection 2022. Front Genet. 2022. PMID: 35480328 Free PMC article.
-
Longitudinal gut microbiota composition of South African and Nigerian infants in relation to tetanus vaccine responses.Res Sq [Preprint]. 2023 Jul 3:rs.3.rs-3112263. doi: 10.21203/rs.3.rs-3112263/v1. Res Sq. 2023. Update in: Microbiol Spectr. 2024 Feb 6;12(2):e0319023. doi: 10.1128/spectrum.03190-23. PMID: 37461449 Free PMC article. Updated. Preprint.
References
-
- Matamoros S, Gras-Leguen C, Le Vacon F, Potel G, de La Cochetiere MF. Development of intestinal microbiota in infants and its impact on health. Trends Microbiol. 2013;21(4):167–173 - PubMed
-
- Bisgaard H, Li N, Bonnelykke K, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol. 2011;128(3):646–652, e641–e645 - PubMed